Depressive symptoms as a factor in neuropsychological test performance: MMPI-2 and selected tests of the Halstead-Reitan/Halstead-Russell Battery
- PMID: 32083959
- DOI: 10.1080/23279095.2020.1720687
Depressive symptoms as a factor in neuropsychological test performance: MMPI-2 and selected tests of the Halstead-Reitan/Halstead-Russell Battery
Abstract
The potential impact of depressive symptoms on neuropsychological test performance has been studied extensively yielding mixed results. Self-report depression inventories have been most often used, without a means to screen participants for response bias. Studies have also neglected to screen participants for incomplete effort in testing. In the present study, 48% of an initial sample of outpatient referrals (N = 247) failed to meet traditional validity criteria. The remaining participants were screened for cerebral pathology and then classified into high and low depressive symptom groups (ns = 46) using the median score on Scale D (Depression) of the MMPI-2. The "high depression" subjects scored over 70 T on the D scale (MN = 80 T). The "low depression" subjects scored below 65 T (MN = 58 T). Age, education, and estimated intelligence were equivalent across groups. Neuropsychological test performances were compared across eight tests: Revised Category Test, Trail Making Test, Part B, Tactual Performance Test (TPT), TPT Memory and Location, Reitan-Indiana Aphasia Screening Test, Seashore Rhythm Test, and the Speech Perception Test. A MANOVA revealed no main effect for group., F(8,69) = 1.05, n.s., and univariate analyses for each test also showed no intergroup differences. The results provide evidence that these neuropsychological tests are appropriately interpreted within a framework of brain-behavior relationships irrespective of an examinee's emotional status.
Keywords: Assessment/diagnosis; diagnosis; embeded measures; psychopathology; tests.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous